Covered recipient · General Payments record
APURVA PADUBIDRI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,315.03
- Reported across 136 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $457.52 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $137.85 | 15 |
| ABBVIE INC. | $53.99 | 3 |
| Lilly USA, LLC | $52.46 | 3 |
| Novo Nordisk AS | $42.11 | 3 |
| Exact Sciences Corporation | $37.30 | 2 |
| Abbott Laboratories | $34.12 | 2 |
| GlaxoSmithKline, LLC. | $32.75 | 2 |
| Acerta Pharma LLC | $32.26 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.66 | 1 |
| Merck Sharp & Dohme Corporation | $15.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.69 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125155035 | CMS |
| Abbott Laboratories | $17.43 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125155033 | CMS |
| ABBVIE INC. | $18.21 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105168386 | CMS |
| ABBVIE INC. | $14.34 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105168388 | CMS |
| ABBVIE INC. | $21.44 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105168390 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.01 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104666803 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.25 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105394495 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.66 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118081982 | CMS |
| Exact Sciences Corporation | $18.32 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114819843 | CMS |
| Exact Sciences Corporation | $18.98 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114819849 | CMS |
| GlaxoSmithKline, LLC. | $15.82 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116444552 | CMS |
| GlaxoSmithKline, LLC. | $16.93 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116030014 | CMS |
| Lilly USA, LLC | $15.18 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136053724 | CMS |
| Lilly USA, LLC | $20.76 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136050311 | CMS |
| Lilly USA, LLC | $16.52 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136050313 | CMS |
| Merck Sharp & Dohme LLC | $15.02 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141947333 | CMS |
| Novo Nordisk Inc | $14.20 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097372118 | CMS |
| Novo Nordisk Inc | $14.27 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097456680 | CMS |
| Novo Nordisk Inc | $13.64 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096678906 | CMS |
| PFIZER INC. | $14.62 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131102099 | CMS |
| PFIZER INC. | $10.20 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131269601 | CMS |
| PFIZER INC. | $0.60 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131270246 | CMS |
| PFIZER INC. | $6.71 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130900628 | CMS |
| PFIZER INC. | $11.70 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131269605 | CMS |
| PFIZER INC. | $6.71 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130901419 | CMS |
| PFIZER INC. | $1.64 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130908368 | CMS |
| PFIZER INC. | $12.74 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130909138 | CMS |
| PFIZER INC. | $18.34 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131635132 | CMS |
| PFIZER INC. | $6.35 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130922411 | CMS |
| PFIZER INC. | $5.28 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130950415 | CMS |
| PFIZER INC. | $11.56 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130958516 | CMS |
| PFIZER INC. | $5.21 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130956046 | CMS |
| PFIZER INC. | $12.23 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130986226 | CMS |
| PFIZER INC. | $13.96 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131197530 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.